加载中
NASDAQHealthcareMedical - Devices
最新数据
US$9.195
+US$0.215 · +2.39%
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
常规交易时段
US$9.195
+US$0.215 · +2.39%
盘中时间采用ET。市场数据可能有所延迟。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日内区间
当前US$9.195
52周区间
当前US$9.195
盘中时间采用ET。市场数据可能有所延迟。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日内区间
当前US$9.195
52周区间
当前US$9.195
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3525.7万 USD | 2247.2万 USD | 2239万 USD | 1638.9万 USD | 1367.5万 USD |
| 销货成本 | 1949.4万 USD | 2193.9万 USD | 1929.9万 USD | 1366.3万 USD | 1448.6万 USD |
| 毛利 | 1576.3万 USD | 53.3万 USD | 309.1万 USD | 272.6万 USD | −81.1万 USD |
| 研究与开发 | 3159.2万 USD | 4114.4万 USD | 4875.2万 USD | 3971.9万 USD | 2721.7万 USD |
| 销售、一般及管理费用 | 5250.8万 USD | 3423.1万 USD | 2994.2万 USD | 3163.4万 USD | 2915.4万 USD |
| 营业费用 | 8410万 USD | 7537.5万 USD | 7869.4万 USD | 7135.3万 USD | 5637.1万 USD |
| 利息收入 | 419.8万 USD | 450.2万 USD | 536.2万 USD | 182.4万 USD | 24.3万 USD |
| 利息支出 | 495.1万 USD | 843.7万 USD | 1111万 USD | 1870.3万 USD | 1672万 USD |
| 折旧和摊销 | 151.2万 USD | 147.5万 USD | 127.7万 USD | 98.5万 USD | 123.9万 USD |
| 营业利润 | −6833.7万 USD | −7484.2万 USD | −7560.3万 USD | −6862.7万 USD | −5718.2万 USD |
| 净利润 | −6911.3万 USD | −7861.6万 USD | −6039.2万 USD | 1.42亿 USD | −3.02亿 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$13.00
上涨空间 41.38%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1084.7万0.00%2.3万亿 USD0.03%US$381.38-0.15%
iShares Russell 2000 ETFIWM882.15万0.01%787.4亿 USD0.19%US$278.24-0.25%
Vanguard Extended Market ETFVXF519.14万0.01%954亿 USD0.05%US$233.86-0.49%
iShares Russell 2000 Growth ETFIWO311.79万0.02%139.17亿 USD0.24%US$354.11-0.75%
Schwab U.S. Small-Cap ETFSCHA234.99万0.01%218.24亿 USD0.03%US$32.705-0.26%
Vanguard Russell 2000 ETFVTWO209.11万0.01%180亿 USD0.06%US$112.39-0.24%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS144.14万0.36%3.99亿 USD0.60%US$106.32-0.86%
iShares Micro-Cap ETFIWC105.86万0.08%13.17亿 USD0.60%US$182-0.55%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOInvesco Dorsey Wright SmallCap Momentum ETFDWASiShares Micro-Cap ETFIWCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
